Gastrointestinal Disorders (Exam 3) Flashcards
Most common GI disorder in the US
GERD
major GI disorders in the US
GERD
IBS
Gallstones
Celiac disease
Crohn’s disease
Ulcerative colitis
Hemorrhoids
Diverticulosis
Colon cancer
cells in the GI tract
pit cell
stem cell
neck cell
parietal cell
chief cell
endocrine cell
which layer of the stomach wall does drugs typically act?
mucosa
types of enzymes in the small intestine
pancreatic enzymes
brush border enzymes
pancreatic enzymes
lipases, amylases, exopeptidase, nucleases
secreted into the intestine, in intestinal lumen
brush border enzymes
embedded in the absorptive cell membranes
carry digestive work, not in lumen
intestinal cells can absorb only
monosaccarhides
digestion of proteins begins in the
stomach
digestion and absorption of lipids
bile salts must emulsify the lipid droplets into smaller ones
micelle
cholesterol
monoglyceride
fatty acid
how does components of a micelle cross the membrane?
cholesterol - carrier protein
monoglycerides and fatty acids - simple diffusion
what happens when the components of a micelle cross the membrane?
triglycerides reform
cholesterol, TG, proteins form chylomicrons
chylomicrons released into lacteal
what types of drugs are used to treat GI disorders?
drugs that neutralize acids
drugs that decrease acid output
drugs that affect GI motility
histamine
produced in enterochromaffin-like cells, mast cells, basophils and neurons
histamine has an important role in
gastric secretion
site of histamine storage is mainly in
mast cells
serotonin
modulation of platelet function and neurotransmission
important role in the gut
serotonin is produced in
enterochromaffin cells, neurons
serotonin is not produced in _____________, only stored there
platelets
precursor of serotonin
tryptophan
5HT1 subtypes and where they act
A-F - brain
P - enteric NS
5HT2 subtypes and where they act
2A - platelets, smooth muscle
2B - stomach
where does 5HT3 act?
vomiting centers - CNS
stomach
what stimulates gastric acid secretion?
acetylcholine, histamine, gastrin
G cells are
gastrin producers
D cells are
somatostatin producers
somatostatins role
inhibits G cell
inhibits gastrin secretion
nerve involved in gastric acid secretion
vagus preganglionic nerve
acetylcholine is present in
D cells
ECL cells
Parietal cells
where is the proton pump located and what is its official name?
in parietal cells
H+K+ ATPase
drugs that neutralize acids
systemic antacids
nonsystematic antacids
systemic antacids
are soluble and reabsorbable
cause systemic alkalosis
example of systemic antacids
sodium bicarbonate
nonsystematic antacids
not absorbed into systemic circulation
do not produce systemic alkalosis
examples of nonsystematic antacids
aluminum containing antacids
calcium containing antacids
magnesium containing antacids
combination antacids
magaldrate
use to treat variety of conditions such as esophagitis, duodenal and gastric ulcers and GERD
mechanism of systemic antacids
in stomach: instantaneous interaction with HCl –> NaCl, water and CO2
in intestines: NaCl + HCO3 to Na+ HCO3
side effects of systemic antacids
hypernatremia
fluid retention
metabolic alkalosis
where part of the MOA of systemic antacids does absorption occur?
in intestines
NaHCO3 –> Na+ and HCO3
Nonsystemic antacids CaCO3 MOA
in stomach: CaCO3 + 2HCl –> CaCl2, water and CO2
in intestines: CaCl2 + HCO3 –> CaCO3 and HCl
CaCO3 reacts slower than
Na+ bicarbonate
side effects of CaCO3
hypercalcemia can trigger gastrin release –> acid rebound
how much of CaCO3 is absorbed (nonsystemic antacid)
about 10%
nonsystematic acids Mg(OH)2 and Al(OH)3 MOA
in stomach: reacts slowly with HCl –> MgCl2 and water
in intestines: MgCl2 and HCO3 –> Mg(OH)2 and HCl
Mg(OH)2 and Al(OH)3 are relatively
insoluble and slow neutralize acid
retention in stomach
side effects of Mg(OH)2
cathartic
can induce N/V
diarrhea
side effects of Al(OH)3
constipation
can bind to antibiotics, antifungals, iron supplements and prevent absorption
toxicity in renal insufficiency
nonsystemic antacids can be combined with
anticholinergic drugs to delay gastric emptying
common anticholinergics combined with nonsystemic antacids
pirenzepine, propantheline and mepenzolate
all act as M1 receptor antagonists
side effects of nonsystemic antacids with anticholinergics
blurry vision
contraindicated with glaucoma
potency of H2 receptor antagonists (from greatest to least)
famotidine > nizatidine = ranitidine > cimetidine
H2 receptor antagonists examples
cimetidine
nizatidine
famotidine
ranitidine (discontinued)
H2 receptor antagonists MOA
competitive H2 receptor antagonist
permissive and transmissive role of histamine
permissive role of histamine
presence of histamine permits action of acetylcholine and gastrin
transmissive role of histamine
histamine is basic and final requirement for acetylcholine and gastrin
how are H2 receptor antagonists metabolized?
hepatic metabolism
glomerular filtration
tubular secretion
H2 receptor antagonists are very effective at
inhibiting nocturnal H+ secretion
which H2 receptor antagonists has little first pass hepatic metabolism?
nizatidine
cimetidine inhibits
CYP450 hepatic drug metabolism
toxicity of H2 receptor antagonists from greatest to least
cimetidine > nizatidine > famotidine > ranitidine
toxicity of H2 receptor antagonists
inhibits dihydrotestosterone binding to androgen receptors
inhibits estradiol metabolism
increase serum prolactin levels
inhibition of hepatic alcohol metabolism
toxicity of H2 receptor antagonists can lead to
Gynecomastia in men
Galactorrhea in women
proton pump inhibitors examples
omeprazole
esomeprazole
rabeprazole
lansoprazole
pantoprazole
MOA of PPIs
non competitive inhibitors of the H+K+ ATPase
PPIs are _____________ and are activated in an _________ environment
prodrugs
acidic
PPIs must pass through the
stomach to be effectively absorbed
PPIs are absorbed in the _______ into ________________ and converted into the __________
intestine
PC vesicles
active form
omeprazole
Prilosec
metabolized in the liver by CYP2C19 and CYP3A4
CYP3A4 converts ___-omeprazole to _________________
S
3-hydroxyomeprazole
__ isomer of omeprazole is the conversion to _________________ by CYP______
R
5-hydroxyomperazole
CYP2C19
metabolites of R-omeprazole
5-hydroxyomeprazole
omeprazole sulfone
5’-O-desmethylomeprazole
3-hydroxyomeprazole
The S-isomer of omeprazole is converted primarily to
5’-O-desmethylomeprazole via CYP2C19
proton pump encodes for which 2 genes?
ATP4A and ATP4B
the binding of the PPI to the ATP4A/ATP4B complex prevents
acid secretion
PPIs enter through
PPIs exit through
diffusion
ATP4A/B transporter
omeprazole brand name and bioavailability
prilosec
40-65%
esomeprazole brand name and bioavailability
Nexium
> 80%
lansoprazole brand name and bioavailability
Prevacid
> 80%
pantoprazole brand name and bioavailability
protonix
77%
rabeprazole brand name and bioavailability
aciphex
52%
dexlansoprazole brand name
dexilant
what is the difference in effects of H2 receptor antagonists and PPIs?
H2 receptor antagonists have a marked effect on nocturnal acid but only a modest effect on meal stimulated acid
PPIs have a markedly suppress both
Adverse effects of PPIs
diarrhea
headache
abdominal pain (1-5%)
increased gastric biota in chronic use
Prostaglandin analogues
misoprostol
misoprostol
PGE1 analogue
EP agonist
Prostaglandin E2 is the most widely
produced prostanoid in the human body
MOA of misoprostol
protects mucus lining in two ways
increases gastric pH and enhances the mucosal barrier that protects the stomach
prostaglandin E receptors
found on parietal cells
when stimulated, have an inhibitory effect on the proton pump
PGE2 acts as a __________ on _____ receptors on parietal cells and __________ activity of the proton pump
agonist
EP3
reduces
PGE2 contributes to the maintenance of
the mucosal barrier, stimulating secretion of mucin and bicarbonate –> enhances mucosal blood flow
PGE2 is synthesized in the
COX pathway
NSAIDs effect on PGE2
NSAIDs inhibit COX enzymes –> reduce amount of PGE2
reduce the amount of protective mucus in the stomach
Misoprostol is typically given as an
adjunct in patents undergoing NSAID therapy, substituting for PGE lost by NSAID use
misoprostol enhances
epithelial mucus and bicarbonate secretion
misoprostol inhibits
histamine induced H release
gastrin release
adverse effects of misoprostol
diarrhea
abortive
bismuth compounds
non rx: bismuth subsalicylate
rx: bismuth substrate potassium
what is included in the formulation of bismuth substrate potassium?
metronidazole
tetracycline
mechanism of bismuth compounds
not clear
coats and protects stomach
antibacterial effect
adverse effects of bismuth compounds
blackening of the stool
types of laxatives
bulk
osmotic
stimulants
stool softeners
bulk laxatives
insoluble and non absorbable
not digestible
examples of bulk laxatives
psyllium
bran
methylcellulose
why do bulk laxatives need to be taken with lots of water?
if they don’t constipation will get worse
bulk laxatives MOA
increase in bowel content volume triggers stretch receptors in intestinal wall
causes reflux contraction and propels contents forward
types of saline and osmotic laxatives
non-digestible sugars and alcohols (lactulose)
salts (milk of magnesia, epsom salt, Glauber’s salt, sodium phosphates and citrate)
polyethylene glycol
lactulose is broken down by
bacteria to acetic and lactic acid which causes the osmotic effect
mechanism of polyethylene glycol
fluid is drawn into the bowel by osmotic force –> increased volume triggers peristalsis –> used to purge intestine
stool softeners examples
docusate sodium
liquid paraffin
glycerin suppositories
docusate MOA
decreases surface tension of fecal matter and allows for water to penetrate feces
adverse effects of stool softeners
excessive use disrupts GI epithelial cells
stimulants examples
Senna
bisacodyl
lubiprostone
lubiprostone
prostanoic acid derivative
stimulates epithelial chloride channel
increases intestinal motility
irritates GI mucosa and pulls water into lumen
lubiprostone is indicated for
severe constipation where rapid effect is required
dopamine D2 receptor antagonists examples
metoclopramide
chlorpromazine
Prochlorperazine
promethazine
haloperidol
droperidol
dopamine receptor antagonists MOA
block dopamine induced attenuation of pro kinetic effects of Ach
inhibition of D2-R in CTZ –> antiemetic effect
dopamine decreases _____________
decreases _________ release from myenteric motor neurons
peristalsis
acetylcholine
metoclopramide pharmacodynamics
primarily D2-R antagonist
5-HT4-R agonist
5-HT3-R antagonist
metoclopramide pharmacokinetics
absorbed rapidly after oral ingestion
undergoes sulfaten and glucuronidation by the liver
metoclopramide adverse effects
crosses BBB
extrapyramidal effects (movement disorders)
tardive dyskinesia (unusual movements of muscles of face)
chemoreceptor trigger zone
induces emesis
sensitive to chemical stimuli
emetics
agents to induce vomiting
emetics examples
emetine
dehydroemetine
apomorphine
emetine and dehydrometine are used as
second or third line of antiprotozoal therapy
dehydroemetine
induces emesis
direct stimulation of CTZ
side effects of dehydroemetine
drowsiness
diarrhea
stomach ache
apomorphine
dopaminergic agonist
treats off episodes in Parkinson’s
antihistamines and anticholinergics examples
dimenhydrinates
hydroxyzine
cyclizine
meclizine
scopolamine
trimethobenzamide
5HT3 receptor antagonist examples
ondansetron
granisetron
dolasetron
ramosetron
tropisetron
alosetron
neurokinin-1 receptor antagonists
aprepitant
fosaprepitant
rolapitant
other anti emetic examples
cannabinoids
nabilone
dronabinol
nabiximol
dexamethasone
netupitant / palonosetron
5HT3 antagonists MOA
5HT3-R antagonism in both peripheral and CNS
ondansetron PK
metabolized in liver –> glucoronide/sulfate conjugation
patents with hepatic dysfunction have reduced plasma clearance of
ondansetron
granisetron PK
metabolized by CYP3A
inhibited by ketoconazole
dolasetron PK
converted by plasma enzymes to active metabolite hydrodolasetron
where is hydrodolasetron metabolized?
2/3 - liver
1/3 - excreted unchanged in urine
palonosetron PK
metabolized 1/2 in liver and 1/2 excreted unchanged in urine
adverse effects of 5HT3 antagonists
headache
dizziness
constipation
Irritable bowel disease
bowel inflammation
no causative agent
systemic manifestations (axial arthritis, eye inflammation, skin lesions)
Crohn disease
inflammation skips lesions
mostly in SI and colon
genetic susceptibility, distinct HLA associations
ulcerative colitis
continuous involvement of colon and rectum
HLA associations likely
what is a risk factor for IBD?
tobacco smoke
IBD is an exaggerated
immune response against normal flora
treatment for Crohn’s disease and ulcerative colitis
coticosteroids
immunomodulators
biologis: HUMIRA
anti TNF antibodies used in IBD
infliximab
adlimumab
certolizumab
golimumab
what do anti-TNF antibodies do?
neutralize soluble TNF (tumor necrosis factor)
release of serotonin by enterochromaffin cells from _________________ stimulates ________________
gut distension
submucosal intrinsic primary afferent neurons
submucosal IPANs activate
the enteric neurons responsible for peristaltic and secretory reflex activity
stimulation of 5HT4 receptors of IPANs enhances
release of Ach and calcitonin gene related peptide, promoting reflex activity
5HT4 partial agonist example
tegaserod
azo compounds include
balsalazide
olsalazine
sulfsalazine
azo compounds are converted by _________________ to ____________________ which is the active therapeutic moiety
bacterial azoreductase
5-aminosalicylic acid (mesalamine)
sites of 5-ASA release from different formulations in the small and large intestine include the
jejunum (SI) - DR C
ileum (SI) - pH dependent release
proximal - sulfasalazine/balsalazide
colon distal - enema
rectum - suppository
anti emetic examples
promethazine
prochlorperazine
chlorperazine
anti emetics MOA
D2 receptor antagonism at the CTZ
anti emetics are of value in
motion sickness
anti emetics are weak ______________ without _______________ activity
DA antagonists
antiphsychotic activity
adverse effects of anti emetics
extra-pyramidal symptoms or other movement disorders
cannabinoids examples
cannabis sativa
cannabis indica
cannabis ruderalis
endocannabinoids examples
anandamide
2-arachidonyl glycerol (2-AG)
active compound that produces the most pharmacological effects of smoked marajuana
delta-9-tetrahydrocannabinol
cannabinoid receptors that have been identified and cloned
CB1 and CB2
the endocannabinoids for the cannabinoid receptors are
arachidonic acid derivatives
cannabis has been used for its
physcotropic effects (sensory perception, elation, euphoria)
medicinal properties (pain relief, nausea and vomiting)
the clinical potential of delta-9 THC against
chemotherapy induced nausea and vomiting (CINV)
synthesis of anandamide
N-arachidonyl phosphotidylethenolamine –> (PLD2) –> Anandamide
synthesis of 2-AG
membrane phospholipid –> PLC to Diacylglycerol (DAG) –> DAG lipase to 2-AG
when anandamide acts on CB1 receptor it inhibits _______________ which acts on ________________
adenylate cyclase
CNS, leukocytes, and testis
when anandamide acts of CB2 receptor it inhibits ________________ which acts on _______________
adenylate cyclase
spleen, tonsils, bone marrow, peripheral blood leukocytes
delta-9-THC anti emetic examples
dronabinol
marinol
pharmacodynamics of delta-9-THC
stimulation of CB1 receptors on neurons in and around the vomiting center in the brainstem
pharmacokinetics of delta-9-THC
highly soluble lipid compound
absorbed readily after oral administration
onset = 1 hour
delta-9-THC undergoes extensive _____________________ with limited ________________
first pass metabolism
systemic bioavailability
principle active metabolite of delta-9-THC
11-OH-delta-9-tetrahydrocannabinol
delta-9-THC is excreted via
biliary fecal route
only ____________ delta-9-THC is excreted in the ____________ and it is highly bound to _____________
10-15%
urine
plasma proteins
adverse effects of delta-9-THC
complex effects on the CNS
can displace other plasma protein bound drugs